Global Musculoskeletal Drugs Market Is Expected To Grow To $177 Billion By 2021 According To TBRC’s Latest Report

The musculoskeletal system drugs market comprises companies that discover, develop, manufacture and distribute medications used in the treatment of musculoskeletal diseases. Musculoskeletal diseases include arthritis, osteoporosis, osteomalacia, carpal tunnel...

The musculoskeletal system drugs market comprises companies that discover, develop, manufacture and distribute medications used in the treatment of musculoskeletal diseases. Musculoskeletal diseases include arthritis, osteoporosis, osteomalacia, carpal tunnel syndrome, tendonitis, rotator cuff tear, muscular dystrophy, myasthenia gravis, lupus erythematosus and others. Some of the major drugs in the market include Piroxicam Glaxo, Dolonex, Felden, and Piroxicam Pfizer.

Read the report at

https://www.thebusinessresearchcompany.com/report/musculoskeletal-disorders-drugs-global-market-report-2018

The substantial reason for the growth of the musculoskeletal system drugs market from $130 billion in 2017 to $177 billion in 2021. This can be attributed to the expected increase in healthcare awareness, number of surgical operations and prevalence of musculoskeletal disorders such as fibromyalgia, rheumatoid arthritis, osteoarthritis around the world.  Also, increasing number of road accidents and workplace injuries are expected to contribute to market growth.

North America was the largest region in the musculoskeletal disorders drugs market in 2017, accounting for almost one-third of the market share.

The market is segmented into: drugs for rheumatoid arthritis, muscle relaxants and others.

Download a sample of the report at

https://www.thebusinessresearchcompany.com/sample.aspx?id=257&type=smp

The USA was the largest country in the musculoskeletal disorders drugs market in 2017, accounting for almost one-sixth of the market share. This can be attributed to the increasing old age population and high per capita healthcare expenditure compared to other countries. The USA was followed by Japan and China.

The top five competitors in the market made up nearly 10% of the total market in 2017. F. Hoffmann-La Roche Ltd. was the largest competitor followed by GlaxosmithKline Plc., Pfizer Inc., Abbott Laboratories Inc. and Daiichi Sankyo Company Limited. F. Hoffmann-La Roche AG is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. The company headquarters are located in Basel.

About The Business Research Company.

The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information.

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: [email protected]

Categories
General Health
No Comment

Leave a Reply

*

*